Literature DB >> 28951699

Does intensity-modulated radiation therapy (IMRT) alter prostate size? Magnetic resonance imaging evaluation of patients undergoing IMRT alone.

Hidekazu Tanaka1, Takahiro Yamaguchi1, Kae Hachiya1, Masahide Hayashi2, Shinichi Ogawa2, Hironori Nishibori2, Shingo Kamei3, Satoshi Ishihara3, Masayuki Matsuo1.   

Abstract

AIM: To assess the changes in prostate size in patients with prostate cancer undergoing intensity-modulated radiation therapy (IMRT).
BACKGROUND: The effect of size change produced by IMRT is not well known.
MATERIALS AND METHODS: We enrolled 72 patients who received IMRT alone without androgen-deprivation therapy and underwent magnetic resonance imaging (MRI) examination before and after IMRT. The diameter of the entire prostate in the anterior-posterior (P-AP) and left-right (P-LR) directions was measured. The transitional zone diameter in the anterior-posterior (T-AP) and left-right (T-LR) directions was also measured.
RESULTS: The average relative P-AP values at 3, 6, 12, 24, and 36 months after IMRT compared to the pre-IMRT value were 0.94, 0.90, 0.89, 0.89, and 0.90, respectively; the average relative P-LR values were 0.93, 0.92, 0.91, 0.91, and 0.90, respectively. The average P-AP and P-LR decreased by approximately 10% during the 12 months post-IMRT, and remained unchanged thereafter. The average relative T-AP values at 3, 6, 12, 24, and 36 months after IMRT compared to the pre-IMRT value were 0.93, 0.88, 0.91, 0.87, and 0.89, respectively; the average relative T-LR values were 0.96, 0.90, 0.91, 0.87, and 0.88, respectively. The average T-AP and T-LR also decreased by approximately 10% during the 12 months post-IMRT, and remained unchanged thereafter. At 12 months after IMRT, the average relative T-AP was significantly lower in patients with recurrence than in those without recurrence.
CONCLUSIONS: The average prostate diameter decreased by approximately 10% during the 12 months after IMRT; thereafter remained unchanged.

Entities:  

Keywords:  External beam radiation therapy; Intensity-modulated radiation therapy; Magnetic resonance imaging; Prostate cancer

Year:  2017        PMID: 28951699      PMCID: PMC5607145          DOI: 10.1016/j.rpor.2017.08.009

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  21 in total

1.  MR and CT image fusion for postimplant analysis in permanent prostate seed implants.

Authors:  Alfredo Polo; Federica Cattani; Andrea Vavassori; Daniela Origgi; Gaetano Villa; Hugo Marsiglia; Massimo Bellomi; Giampiero Tosi; Ottavio De Cobelli; Roberto Orecchia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

Review 2.  Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer.

Authors:  Vikas Kundra; Paul M Silverman; Surena F Matin; Haesun Choi
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

3.  Variations in international prostate symptom scores, uroflowmetric parameters, and prostate volume after (125)I permanent brachytherapy for localized prostate cancer.

Authors:  Nobumichi Tanaka; Kiyohide Fujimoto; Yoshihiko Hirao; Isao Asakawa; Masatoshi Hasegawa; Noboru Konishi
Journal:  Urology       Date:  2009-04-18       Impact factor: 2.649

4.  Comparing morbidity and cancer control after 3D-conformal (70/74 Gy) and intensity modulated radiotherapy (78/82 Gy) for prostate cancer.

Authors:  Martin Dolezel; Karel Odrazka; Milan Zouhar; Miloslava Vaculikova; Jana Sefrova; Jan Jansa; Petr Paluska; Tereza Kohlova; Jaroslav Vanasek; Josef Kovarik
Journal:  Strahlenther Onkol       Date:  2015-01-15       Impact factor: 3.621

5.  Dosimetric impact in the dose-volume histograms of rectal and vesical wall contouring in prostate cancer IMRT treatments.

Authors:  Laura Gómez; Carlos Andrés; Antonio Ruiz
Journal:  Rep Pract Oncol Radiother       Date:  2017-04-21

Review 6.  The morphologic changes induced by hormone and radiation therapy on prostate carcinoma.

Authors:  Silvia Lăcrămioara Roznovanu; Doiniţa Rădulescu; C Novac; Simona Stolnicu
Journal:  Rev Med Chir Soc Med Nat Iasi       Date:  2005 Apr-Jun

7.  Magnetic resonance imaging anatomy of the prostate and periprostatic area: a guide for radiotherapists.

Authors:  Geert M Villeirs; Koenraad L Verstraete; Wilfried J De Neve; Gert O De Meerleer
Journal:  Radiother Oncol       Date:  2005-07       Impact factor: 6.280

8.  Preliminary results of intensity-modulated radiation therapy with helical tomotherapy for prostate cancer.

Authors:  Natsuo Tomita; Norihito Soga; Yuji Ogura; Norio Hayashi; Hidetoshi Shimizu; Takashi Kubota; Junji Ito; Kimiko Hirata; Yukihiko Ohshima; Hiroyuki Tachibana; Takeshi Kodaira
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-01       Impact factor: 4.553

9.  Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era.

Authors:  Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Kerri Cote; Marian Loffredo; Delray Schultz; Ming-Hui Chen; John E Tomaszewski; Andrew A Renshaw; Alan Wein; Jerome P Richie
Journal:  Cancer       Date:  2002-07-15       Impact factor: 6.860

10.  MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.

Authors:  Juanita Crook; Michael McLean; Ivan Yeung; Theresa Williams; Gina Lockwood
Journal:  Brachytherapy       Date:  2004       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.